Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
ImmunoGen, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2026 | $757.20M | $628.22M - $900.73M | -$597.84M | $0.855 | 11 |
| Dec 2025 | $538.20M | $375.24M - $607.00M | -$424.93M | $0.348 | 11 |
| Dec 2024 | $493.74M | $375.20M - $607.01M | -$178.59M | $0.05 | 12 |
| Dec 2023 | $357.03M | $341.60M - $413.32M | -$179.53M | -$0.05 | 11 |
| Dec 2022 | $74.54M | $61.84M - $88.67M | -$156.16M | -$0.74 | 6 |
| Dec 2021 | $92.24M | $76.53M - $109.73M | $74.18M | -$0.45 | 6 |
| Dec 2020 | $114.12M | $94.68M - $135.75M | -$58.29M | -$0.77 | 5 |
| Dec 2019 | $51.46M | $42.70M - $61.22M | -$146.35M | -$1.23 | 4 |
| Dec 2018 | $156.56M | $129.89M - $186.23M | -$88.85M | -$0.85 | 5 |
| Dec 2017 | $41.38M | $34.33M - $49.22M | -$100.90M | -$1.48 | 5 |
| Dec 2016 | $53.99M | $44.79M - $64.22M | -$92.86M | -$1.26 | 4 |
| Dec 2015 | $38.31M | $31.79M - $45.57M | $8.90M | -$0.67 | 5 |